EKTERLY

Serial Number 97832368
Registration 7358603
700

Registration Progress

Application Filed
Mar 10, 2023
Under Examination
Approved for Publication
Jan 30, 2024
Published for Opposition
Jan 30, 2024
Registered
Apr 16, 2024

Trademark Image

EKTERLY

Basic Information

Serial Number
97832368
Registration Number
7358603
Filing Date
March 10, 2023
Registration Date
April 16, 2024
Published for Opposition
January 30, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 16, 2024
Registration
Registered
Classes
005

Rights Holder

Kalvista Pharmaceuticals Limited

99
Address
Bybrook Road, Porton Down Salisbury
Porton Science Park
Wiltshire SP40BF
GB

Ownership History

Kalvista Pharmaceuticals Limited

Original Applicant
99
Wiltshire GB

Kalvista Pharmaceuticals Limited

Owner at Publication
99
Wiltshire GB

Kalvista Pharmaceuticals Limited

Original Registrant
99
Wiltshire GB

Legal Representation

Attorney
Stacy L. Wu

USPTO Deadlines

Next Deadline
1566 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240416)
Due Date
April 16, 2030
Grace Period Ends
October 16, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Oct 9, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Oct 9, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 9, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 9, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 9, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 9, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 16, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 16, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 30, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 30, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 10, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 27, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 26, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 26, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 26, 2023 ALIE A ASSIGNED TO LIE Loading...
Jul 31, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 12, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 12, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 12, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 5, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 30, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 14, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; pharmaceutical preparations containing sebetralstat for the treatment of angioedema, hereditary angioedema, bradykinin mediated inflammatory disorders, plasma kallikrein or factor XIIa mediated diseases or disorders, or diseases and disorders mediated by the contact activation system

Classification

International Classes
005